NCT04161248 2026-02-02Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell LymphomaCanadian Cancer Trials GroupPhase EARLY_PHASE1 Recruiting18 enrolled
NCT05476770 2024-12-06Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic MalignanciesTherapeutic Advances in Childhood Leukemia ConsortiumPhase 1 Recruiting54 enrolled